Free Trial

Compass Therapeutics (CMPX) Earnings Date, Estimates & Call Transcripts

Compass Therapeutics logo
$1.90 -0.05 (-2.31%)
As of 03:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Compass Therapeutics Earnings Summary

Compass Therapeutics posted Q1 2026 earnings on May 5, 2026, reporting an EPS of -$0.10, which met analysts' consensus estimates of -$0.10. With a trailing EPS of -$0.43, Compass Therapeutics' earnings are expected to grow next year, from ($0.44) to ($0.42) per share.

Upcoming Q2
Earnings Date
May. 14Before Market OpensEstimated
Consensus EPS
(May. 5)
-$0.10
Actual EPS
(May. 5)
-$0.10

Q1 2026 Earnings Resources

CMPX Upcoming Earnings

Compass Therapeutics' Q1 2026 earnings is estimated for Thursday, May 14, 2026, based on past reporting schedules

Get Compass Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Compass Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CMPX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Compass Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20264-$0.14-$0.09-$0.12
Q2 20264-$0.13-$0.10-$0.11
Q3 20264-$0.25-$0.05-$0.13
Q4 20264-$0.11$0.00-$0.08

Compass Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/14/2026
(Estimated)
--------
5/5/2026Q1 2026-$0.10-$0.10--$0.10--
3/5/2026Q4 2025-$0.10-$0.09+$0.01-$0.09-$0.90M-
11/5/2025Q3 2025-$0.14-$0.08+$0.06-$0.08--
8/11/2025Q2 2025-$0.13-$0.14 -$0.01-$0.14--
5/8/2025Q1 2025-$0.12-$0.12--$0.12--
2/27/2025Q4 2024-$0.10-$0.11 -$0.01-$0.11--
11/12/2024--$0.11-$0.08+$0.03-$0.08--
8/12/2024--$0.10-$0.10--$0.10-$0.85M
5/13/2024Q1 2024-$0.11-$0.08+$0.03-$0.08--

Data powered by Fiscal.ai.

Compass Therapeutics Earnings - Frequently Asked Questions

Compass Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 14th, 2026 based off last year's report dates. Learn more on CMPX's earnings history.

In the previous quarter, Compass Therapeutics (NASDAQ:CMPX) reported ($0.10) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.10). Learn more on analysts' earnings estimate vs. CMPX's actual earnings.

Compass Therapeutics (NASDAQ:CMPX) has a recorded annual revenue of $850,000.00.

Compass Therapeutics (NASDAQ:CMPX) has a recorded net income of -$66.49 million. CMPX has generated -$0.43 earnings per share over the last four quarters.

Compass Therapeutics' earnings are expected to grow from ($0.44) per share to ($0.42) per share in the next year.


This page (NASDAQ:CMPX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners